Non Small Cell Lung Cancer Clinical Trials

202 studies are recruiting for non small cell lung cancer in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Houston, Texas 83 New York, New York 66 Nashville, Tennessee 51 Fairfax, Virginia 46 Boston, Massachusetts 44 Los Angeles, California 43 Chicago, Illinois 29 St Louis, Missouri 29 San Antonio, Texas 28 Seattle, Washington 28 Dallas, Texas 27 Cleveland, Ohio 26 Philadelphia, Pennsylvania 25 Columbus, Ohio 24 Pittsburgh, Pennsylvania 24 Baltimore, Maryland 23 Jacksonville, Florida 23 New Haven, Connecticut 22 Tampa, Florida 22 Detroit, Michigan 21 Grand Rapids, Michigan 21 Portland, Oregon 21 Atlanta, Georgia 20 Salt Lake City, Utah 20 Cincinnati, Ohio 19 La Jolla, California 19 Miami, Florida 19 Rochester, Minnesota 19 Duarte, California 18 Orlando, Florida 18 Austin, Texas 16 Orange, California 16 San Francisco, California 16 Irvine, California 15 Omaha, Nebraska 15 Santa Monica, California 15 Washington D.C., District of Columbia 15 Aurora, Colorado 14 Basking Ridge, New Jersey 14 Commack, New York 14 Denver, Colorado 14 Middletown, New Jersey 14 Montvale, New Jersey 14 Birmingham, Alabama 13 Harrison, New York 13 Indianapolis, Indiana 13 Louisville, Kentucky 13 Newport Beach, California 13 Orange City, Florida 13 Iowa City, Iowa 12 Memphis, Tennessee 12 Reno, Nevada 12 Sacramento, California 12 St. Petersburg, Florida 12 Bethesda, Maryland 11 Beverly Hills, California 11 Chapel Hill, North Carolina 11 Lincoln, Nebraska 11 The Bronx, New York 11 West Palm Beach, Florida 11

Studies, page 9

  1. I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy

    I3LUNG is an international project aiming to develop a medical device to predict immunotherapy efficacy for NSCLC patients using the integration of multisource data (real word and multi-omics data). This objective will be reached through a retrospective - setting up a transnational platform of avai…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Chicago, Chicago, Illinois
    Locations
    4 in total
    Run by
    Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

    See if you can join NCT05537922 on ClinicalTrials.gov

  2. First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies

    This is a first in human phase 1 study of AG01 an anti-Progranulin/Glycoprotein88 (PGRN/GP88) antibody in patients with advanced solid tumors. AG01 is a recombinant monoclonal antibody expressed in a CHO production cell line. The antibody AG01 binds to human PGRN/GP88, expressed on cancer cells. Th…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland
    Run by
    A&G Pharmaceutical Inc.

    See if you can join NCT05627960 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.